COVID-19 systematic screening of asymptomatic haematopoietic stem cell donors: Less if often more

被引：1

作者：

Blandin, Lucie ^{[1
]}

Tolmer, Elise ^{[1
]}

Hermet, Eric ^{[2
]}

Ravinet, Aurelie ^{[2
]}

Brebion, Amelie ^{[3
]}

Lemal, Richard ^{[1
,4
]}

Rouzaire, Paul ^{[1
,4
]}

机构：

[1] Clermont Ferrand Univ Hosp, Histocompatibil & Immunogenet Lab, Clermont Ferrand, France

[2] Clermont Ferrand Univ Hosp, Cellular Therapy & Clin Haematol Dept, Clermont Ferrand, France

[3] Clermont Ferrand Univ Hosp, Virol Lab, Clermont Ferrand, France

[4] Clermont Auvergne Univ, CHELTER EA7453, Clermont Ferrand, France

来源：

EJHAEM | 2022年 / 3卷 / 04期

关键词：

covid; HSC TRANSPLANTATION; donors; TRANSPLANTATION; SARS-COV-2;

D O I：

10.1002/jha2.556

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

From COVID pandemic spread until now, many HSCT unrelated donor registries recommend as a precaution a systematic COVID-19 testing for all donors during the precollection time. Literature is quite poor to support this systematic attitude. We report one sibling allogeneic HSCT which we proceeded despite a positive COVID test on related asymptomatic donor and summarize the all seven cases reported until now. We suggest to question this systematic COVID testing, two years after pandemic began, when there is no systematic testing on other blood products received during all the haematological malignancies treatment process.

引用

页码：1381 / 1384

页数：4